SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer informs about issuance of duplicate certificate

06 Oct 2021 Evaluate

Pursuant to Regulation 39 (3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has informed that the Registrar and Transfer Agent of the Company, KFin Technologies has received request for issue of duplicate Share Certificate(s) from the Shareholder(s). The company will issue the duplicate Share Certificate(s) upon completion of necessary formalities by the shareholder(s). Details of the shareholders and share certificate are attached.

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

4927.75 58.50 (1.20%)
17-Apr-2026 14:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1676.65
Dr. Reddys Lab 1228.00
Cipla 1237.45
Zydus Lifesciences 945.10
Lupin 2313.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×